Across TCGA pan-cancer cohorts, CCNYL4 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CCNYL4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CCNYL4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CCNYL4 is over-expressed in tumor.

KIRC, KIRP, and THCA are the cancer types where CCNYL4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCNYL4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.060	<.001	5	view →
KIRP	Female	All	+0.092	.031	2	view →
THCA	Female	III,IV	+0.062	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: CCNYL4 RNA expression & survival · all CCNYL4 data types